Buy or sell Verge Genomics stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Verge Genomics Stock

Verge Genomics is looking to find cures for brain diseases.

About Verge Genomics Stock

Verge Genomics is looking to find cures for brain diseases. Alzheimers, ALS, and Parkinsons are complex diseases that usually involve a network of genes, as opposed to a single gene.

Funding History

August 2015$120K
October 2015$4.0M
July 2018$32.0M

Management

Co-founder

Jason Chen

Director, Drug Discovery

Irene Choi

Chief Scientific Officer

Anthony Altar

Co-Founder & CEO

Alice Zhang

Director, Operations & Finance

Lucia Huang

Head of Computational Biology

Victor Hanson-Smith

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Verge Genomics or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 80K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo